Ultra-processed food is associated with features of metabolic syndrome and non-alcoholic fatty liver disease
Dana Ivancovsky-Wajcman
School of Public Health, University of Haifa, Haifa, Israel
Search for more papers by this authorNaomi Fliss-Isakov
Department of Gastroenterology, Tel Aviv Medical Center, Tel Aviv, Israel
Search for more papers by this authorMuriel Webb
Department of Gastroenterology, Tel Aviv Medical Center, Tel Aviv, Israel
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for more papers by this authorItay Bentov
Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, USA
Search for more papers by this authorOren Shibolet
Department of Gastroenterology, Tel Aviv Medical Center, Tel Aviv, Israel
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for more papers by this authorRevital Kariv
Department of Gastroenterology, Tel Aviv Medical Center, Tel Aviv, Israel
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for more papers by this authorCorresponding Author
Shira Zelber-Sagi
School of Public Health, University of Haifa, Haifa, Israel
Department of Gastroenterology, Tel Aviv Medical Center, Tel Aviv, Israel
Correspondence
Shira Zelber-Sagi, School of Public Health, Faculty of Social Welfare and Health Sciences, University of Haifa, 199 Aba Khoushy Ave., Haifa 3498838, Israel.
Email: [email protected]
Search for more papers by this authorDana Ivancovsky-Wajcman
School of Public Health, University of Haifa, Haifa, Israel
Search for more papers by this authorNaomi Fliss-Isakov
Department of Gastroenterology, Tel Aviv Medical Center, Tel Aviv, Israel
Search for more papers by this authorMuriel Webb
Department of Gastroenterology, Tel Aviv Medical Center, Tel Aviv, Israel
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for more papers by this authorItay Bentov
Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, USA
Search for more papers by this authorOren Shibolet
Department of Gastroenterology, Tel Aviv Medical Center, Tel Aviv, Israel
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for more papers by this authorRevital Kariv
Department of Gastroenterology, Tel Aviv Medical Center, Tel Aviv, Israel
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for more papers by this authorCorresponding Author
Shira Zelber-Sagi
School of Public Health, University of Haifa, Haifa, Israel
Department of Gastroenterology, Tel Aviv Medical Center, Tel Aviv, Israel
Correspondence
Shira Zelber-Sagi, School of Public Health, Faculty of Social Welfare and Health Sciences, University of Haifa, 199 Aba Khoushy Ave., Haifa 3498838, Israel.
Email: [email protected]
Search for more papers by this authorFunding information
Research Grants and Fellowships Fund on Food and Nutrition and their Implications on Public Health, the Israeli Ministry of Health.
Handling Editor: Salvatore Petta
Abstract
Background & aims
High consumption of ultra-processed food (UPF) is associated with mortality and chronic morbidity but has not been studied concerning to non-alcoholic fatty liver disease (NAFLD). We aimed to test the association of UPF consumption with metabolic syndrome, NAFLD and related-liver damage.
Methods
A cross-sectional study among volunteers who underwent abdominal ultrasound (AUS), anthropometrics, blood pressure measurements, and fasting blood tests including FibroMax for non-invasive assessment of NASH and significant fibrosis. A food-frequency questionnaire was used to evaluate UPF consumption using the NOVA classification.
Results
A total of 789 subjects were included in the total sample (mean age 58.83 ± 6.58 years, 52.60% men), a reliable FibroMax test was obtained from 714 subjects, 305 subjects were diagnosed with NAFLD. High consumption of UPF was associated with higher odds for metabolic syndrome (OR = 1.88, 95% CI 1.31-2.71, P = .001) and its components; hypertension, hypertriglyceridemia, and low HDL, among the entire sample (OR = 1.53, 1.07-2.19, P = .026; OR = 1.51, 1.08-2.11, P = .017; OR = 1.55, 1.05-2.29, P = .028). In addition, it was associated with higher odds for NASH and hypertension (OR = 1.89, 1.07-3.38, P = .030; OR = 2.26, 1.20-4.26, P = .012 respectively) among subjects with NAFLD. Stratification by smoking status revealed an association between high UPF consumption and significant fibrosis among ever smokers in the entire sample and among subjects with NAFLD (OR = 1.89, 95% CI 1.03-3.45, P = .039; OR = 2.85, 1.14-7.14, P = .026 respectively).
Conclusions
High UPF consumption is associated with metabolic syndrome in the general population, and among those with NAFLD it is associated with NASH marker. Ever-smoking may act synergistically with UPF to amplify the risk for fibrosis.
CONFLICT OF INTEREST
None.
REFERENCES
- 1Monteiro CA, Cannon G, Lawrence M, Costa Louzada ML. Ultra-Processed Foods, Diet Quality, and Health Using the NOVA Classification System. Rome: FAO; 2019.
- 2Martinez Steele E, Popkin BM, Swinburn B, Monteiro CA. The share of ultra-processed foods and the overall nutritional quality of diets in the US: evidence from a nationally representative cross-sectional study. Popul Health Metr. 2017; 15(1): 6.
- 3Slimani N, Deharveng G, Southgate DAT, et al. Contribution of highly industrially processed foods to the nutrient intakes and patterns of middle-aged populations in the European Prospective Investigation into Cancer and Nutrition study. Eur J Clin Nutr. 2009; 63(Suppl 4): S206-S225.
- 4Martinez Steele E, Baraldi LG, Louzada ML, Moubarac JC, Mozaffarian D, Monteiro CA. Ultra-processed foods and added sugars in the US diet: evidence from a nationally representative cross-sectional study. BMJ Open. 2016; 6(3):e009892.
- 5Rauber F, Louzada MLdC, Martinez Steele E, et al. Ultra-processed foods and excessive free sugar intake in the UK: a nationally representative cross-sectional study. BMJ Open. 2019; 9(10):e027546.
- 6Mendonca RD, Lopes AC, Pimenta AM, Gea A, Martinez-Gonzalez MA, Bes-Rastrollo M. Ultra-processed food consumption and the incidence of hypertension in a mediterranean cohort: The Seguimiento Universidad de Navarra Project. Am J Hypertens. 2017; 30(4): 358-366.
- 7Fiolet T, Srour B, Sellem L, et al. Consumption of ultra-processed foods and cancer risk: results from NutriNet-Sante prospective cohort. BMJ. 2018; 360:k322.
- 8Lane MM, Davis JA, Beattie S, et al. Ultraprocessed food and chronic noncommunicable diseases: a systematic review and meta-analysis of 43 observational studies. Obes Rev. 2021; 22:e13146. https://doi.org/10.1111/obr.13146
- 9Srour B, Fezeu LK, Kesse-Guyot E, et al. Ultraprocessed food consumption and risk of type 2 diabetes among participants of the nutrinet-sante prospective cohort. JAMA Intern Med. 2020; 180(2): 283-291.
- 10Schnabel L, Kesse-Guyot E, Allès B, et al. Association between ultraprocessed food consumption and risk of mortality among middle-aged adults in France. JAMA Intern Med. 2019; 179(4): 490-498.
- 11Hall KD, Ayuketah A, Brychta R, et al. Ultra-processed diets cause excess calorie intake and weight gain: an inpatient randomized controlled trial of ad libitum food intake. Cell Metab. 2019; 30(1): 226.
- 12Zelber-Sagi S, Ivancovsky-Wajcman D, Fliss Isakov N, et al. High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance. J Hepatol. 2018; 68(6): 1239-1246.
- 13Akhavan Rezayat A, Dadgar Moghadam M, Ghasemi Nour M, et al. Association between smoking and non-alcoholic fatty liver disease: a systematic review and meta-analysis. SAGE Open Med. 2018; 6:2050312117745223.
- 14Kim NH, Jung YS, Hong HP, et al. Association between cotinine-verified smoking status and risk of nonalcoholic fatty liver disease. Liver Int. 2018; 38(8): 1487-1494.
- 15Okamoto M, Miyake T, Kitai K, et al. Cigarette smoking is a risk factor for the onset of fatty liver disease in nondrinkers: a longitudinal cohort study. PLoS ONE. 2018; 13(4):e0195147.
- 16Liu P, Xu Y, Tang Y, et al. Independent and joint effects of moderate alcohol consumption and smoking on the risks of non-alcoholic fatty liver disease in elderly Chinese men. PLoS ONE. 2017; 12(7):e0181497.
- 17Jung H-S, Chang Y, Kwon M-J, et al. Smoking and the risk of non-alcoholic fatty liver disease: a cohort study. Am J Gastroenterol. 2019; 114(3): 453-463.
- 18Zein CO, Unalp A, Colvin R, Liu YC, McCullough AJ, Nonalcoholic Steatohepatitis Clinical Research Network. Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease. J Hepatol. 2011; 54(4): 753-759.
- 19Keinan-Boker L, Noyman N, Chinich A, Green MS, Nitzan-Kaluski D. Overweight and obesity prevalence in Israel: findings of the first national health and nutrition survey (MABAT). Isr Med Assoc J. 2005; 7(4): 219-223.
- 20Munteanu M, Tiniakos D, Anstee Q, et al. Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference. Aliment Pharmacol Ther. 2016; 44(8): 877-889.
- 21Poynard T, Munteanu M, Charlotte F, et al. Diagnostic performance of a new noninvasive test for nonalcoholic steatohepatitis using a simplified histological reference. Eur J Gastro Hepatol. 2018; 30(5): 569-577.
- 22Morra R, Munteanu M, Imbert-Bismut F, Messous D, Ratziu V, Poynard T. FibroMAX™: towards a new universal biomarker of liver disease? Future Drugs Ltd. 2009; 7(5): 481-490.
- 23Kowdley KV, Belt P, Wilson LA, et al. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology. 2012; 55(1): 77-85.
- 24Buzzetti E, Petta S, Manuguerra R, et al. Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease. Liver Int. 2019; 39(7): 1325-1334.
- 25Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019; 74(10): e177-e232.
- 26O'Halloran SA, Lacy KE, Grimes CA, Woods J, Campbell KJ, Nowson CA. A novel processed food classification system applied to Australian food composition databases. J Hum Nutr Diet. 2017; 30(4): 534-541.
- 27Pagliai G, Dinu M, Madarena MP, Bonaccio M, Iacoviello L, Sofi F. Consumption of ultra-processed foods and health status: a systematic review and meta-analysis. Br J Nutr. 2021; 125(3): 308-318.
- 28Chen X, Zhang Z, Yang H, et al. Consumption of ultra-processed foods and health outcomes: a systematic review of epidemiological studies. Nutr J. 2020; 19(1): 86.
- 29Martinez Steele E, Juul F, Neri D, Rauber F, Monteiro CA. Dietary share of ultra-processed foods and metabolic syndrome in the US adult population. Prev Med. 2019; 125: 40-48.
- 30Lavigne-Robichaud M, Moubarac JC, Lantagne-Lopez S, et al. Diet quality indices in relation to metabolic syndrome in an Indigenous Cree (Eeyouch) population in northern Quebec, Canada. Public Health Nutr. 2018; 21(1): 172-180.
- 31Tavares LF, Fonseca SC, Garcia Rosa ML, Yokoo EM. Relationship between ultra-processed foods and metabolic syndrome in adolescents from a Brazilian Family Doctor Program. Public Health Nutr. 2012; 15(1): 82-87.
- 32Nasreddine L, Tamim H, Itani L, et al. A minimally processed dietary pattern is associated with lower odds of metabolic syndrome among Lebanese adults. Public Health Nutr. 2018; 21(1): 160-171.
- 33Srour B, Fezeu LK, Kesse-Guyot E, et al. Ultraprocessed food consumption and risk of type 2 diabetes among participants of the nutrinet-sante prospective cohort. JAMA Intern Med. 2020; 180(2): 283-291.
- 34Kim H, Hu EA, Rebholz CM. Ultra-processed food intake and mortality in the USA: results from the Third National Health and Nutrition Examination Survey (NHANES III, 1988–1994). Public Health Nutr. 2019; 22(10): 1777-1785.
- 35Srour B, Fezeu LK, Kesse-Guyot E, et al. Ultra-processed food intake and risk of cardiovascular disease: prospective cohort study (NutriNet-Sante). BMJ. 2019; 365: l1451.
- 36Scicali R, Giral P, D'Erasmo L, et al. High TG to HDL ratio plays a significant role on atherosclerosis extension in prediabetes and newly diagnosed type 2 diabetes subjects. Diabetes Metab Res Rev. 2021; 37(2):e3367.
- 37Young KA, Maturu A, Lorenzo C, et al. The triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio as a predictor of insulin resistance, beta-cell function, and diabetes in Hispanics and African Americans. J Diabetes Complications. 2019; 33(2): 118-122.
- 38Canhada SL, Luft VC, Giatti L, et al. Ultra-processed foods, incident overweight and obesity, and longitudinal changes in weight and waist circumference: the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Public Health Nutr. 2020; 23(6): 1076-1086.
- 39Rauber F, Steele EM, Louzada M, Millett C, Monteiro CA, Levy RB. Ultra-processed food consumption and indicators of obesity in the United Kingdom population (2008–2016). PLoS ONE. 2020; 15(5):e0232676.
- 40Adams J, White M. Characterisation of UK diets according to degree of food processing and associations with socio-demographics and obesity: cross-sectional analysis of UK National Diet and Nutrition Survey (2008–12). Int J Behav Nutr Phys Act. 2015; 12: 160.
- 41Askari M, Heshmati J, Shahinfar H, Tripathi N, Daneshzad E. Ultra-processed food and the risk of overweight and obesity: a systematic review and meta-analysis of observational studies. Int J Obes (Lond). 2020; 44(10): 2080-2091.
- 42Sanchez-Jimenez BA, Brizuela-Alcantara D, Ramos-Ostos MH, Alva-Lopez LF, Uribe-Esquivel M, Chavez-Tapia NC. Both alcoholic and non-alcoholic steatohepatitis association with cardiovascular risk and liver fibrosis. Alcohol. 2018; 69: 63-67.
- 43Singh S, Allen AM, Wang Z, Prokop LJ, Murad MH, Loomba R. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol. 2015; 13(4): 643-654 e641–e649; quiz e639–e640.
- 44Ciardullo S, Monti T, Sala I, Grassi G, Mancia G, Perseghin G. Nonalcoholic fatty liver disease and advanced fibrosis in US adults across blood pressure categories. Hypertension. 2020; 76(2): 562-568.
- 45Romero-Gomez M, Zelber-Sagi S, Trenell M. Treatment of NAFLD with diet, physical activity and exercise. J Hepatol. 2017; 67(4): 829-846.
- 46Mosca A, Nobili V, De Vito R, et al. Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents. J Hepatol. 2017; 66(5): 1031-1036.
- 47Abdelmalek MF, Suzuki A, Guy C, et al. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology. 2010; 51(6): 1961-1971.
- 48Hyogo H, Yamagishi S-I, Iwamoto K, et al. Elevated levels of serum advanced glycation end products in patients with non-alcoholic steatohepatitis. J Gastroenterol Hepatol. 2007; 22(7): 1112-1119.
- 49Habermeyer M, Roth A, Guth S, et al. Nitrate and nitrite in the diet: how to assess their benefit and risk for human health. Mol Nutr Food Res. 2015; 59(1): 106-128.
- 50Partridge D, Lloyd KA, Rhodes JM, Walker AW, Johnstone AM, Campbell BJ. Food additives: assessing the impact of exposure to permitted emulsifiers on bowel and metabolic health - introducing the FADiets study. Nutrition bulletin. 2019; 44(4): 329-349.
- 51Etemadi A, Sinha R, Ward MH, et al. Mortality from different causes associated with meat, heme iron, nitrates, and nitrites in the NIH-AARP Diet and Health Study: population based cohort study. BMJ. 2017; 357:j1957.
- 52Chassaing B, Koren O, Goodrich JK, et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature. 2015; 519(7541): 92-96.
- 53Zinocker MK, Lindseth IA. The western diet-microbiome-host interaction and its role in metabolic disease. Nutrients. 2018; 10(3).
- 54da Rocha BRS, Rico-Campà A, Romanos-Nanclares A, et al. Adherence to Mediterranean diet is inversely associated with the consumption of ultra-processed foods among Spanish children: the SENDO project. Public Health Nutr. 2020; 1-10.
- 55 European Association for Study of Liver; Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015; 63(1): 237-264.
Citing Literature
